Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Sentinelli, Federica ^a   Romeo, Stefano ^a,b,d   Maglio, Cristina ^c,d   Incani, Michela ^a   Burza, Maria A ^d   Scano, Francesca ^a   Coccia, Federica ^c   Cossu, Efisio ^a   Leonetti, Frida ^c   Baroni, Marco G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

atherogenic dyslipidemia; BMI; HDL; hepatic transaminases; NAFLD; obesity; tryglicerides

Indexed keywords

ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN C3; ASPARTATE AMINOTRANSFERASE; GLUCOSE; INSULIN; LIPID;

ADULT; ALLELE; ARTICLE; DISEASE PREDISPOSITION; FATTY LIVER; FEMALE; GENE SEQUENCE; GENOTYPE; GLUCOSE TOLERANCE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTHERN EUROPE; BLOOD; ECHOGRAPHY; GENETIC ASSOCIATION; GENETICS; ITALY; LIPID METABOLISM; MIDDLE AGED; MORBID OBESITY;

ADULT; APOLIPOPROTEIN C-III; FATTY LIVER; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INSULIN RESISTANCE; ITALY; LIPID METABOLISM; LIPIDS; MALE; MIDDLE AGED; OBESITY, MORBID; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79958160803     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-93     Document Type: Article

References (29)

1. Mechanisms of disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. M Roden, Nat Clin Pract Endocrinol Metab 2006 2 335 348 10.1038/ncpendmet0190 16932311 (Pubitemid 43885913)
2. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. LA Adams JF Lymp J St Sauver SO Sanderson KD Lindor A Feldstein P Angulo, Gastroenterology 2005 129 113 121 10.1053/j.gastro.2005.04.014 16012941 (Pubitemid 41002048)
3. Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. J Westerbacka A Cornér M Tiikkainen M Tamminen S Vehkavaara AM Häkkinen J Fredriksson H Yki-Järvinen, Diabetologia 2004 47 1360 1369 15309287 (Pubitemid 39232420)
4. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. RK Schindhelm M Diamant JM Dekker ME Tushuizen T Teerlink RJ Heine, Diabetes Metab Res Rev 2006 22 6 437 443 10.1002/dmrr.666 16832839 (Pubitemid 44774047)
5. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. KF Petersen S Dufour A Hariri C Nelson-Williams JN Foo XM Zhang J Dziura RP Lifton GI Shulman, N Engl J Med 2010 362 1082 1089 10.1056/NEJMoa0907295 20335584
6. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. MC Jong MH Hofker LM Havekes, Arterioscler Thromb Vasc Biol 1999 19 472 4847 10073946
7. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. A Fredenrich LM Giroux M Tremblay L Krimbou J Davignon JS Cohn, J Lipid Res 1997 38 1421 1432 9254067 (Pubitemid 27332568)
8. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. HN Ginsberg NA Le IJ Goldberg JC Gibson A Rubinstein P Wang-Iverson R Norum WV Brown, J Clin Invest 1986 78 1287 1295 10.1172/JCI112713 3095375 (Pubitemid 17181567)
9. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III. WJ McConathy JC Gesquiere H Bass A Tartar JC Fruchart CS Wang, J Lipid Res 1992 33 995 1003 1431591
10. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. J Kozlitina E Boerwinkle JC Cohen HH Hobbs, Hepatology 2011 53 2 467 474 10.1002/hep.24072 21274868
11. Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. S Romeo F Sentinelli S Dash GS Yeo DB Savage F Leonetti D Capoccia M Incani C Maglio M Iacovino S O'Rahilly MG Baroni, Int J Obes 2010 34 190 194 10.1038/ijo.2009.216
12. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. S Romeo F Sentinelli VM Cambuli M Incani T Congiu V Matta S Pilia I Huang-Doran E Cossu S Loche MG Baroni, J Hepatol 2010 53 2 335 338 10.1016/j.jhep.2010.02.034 20546964
13. Persistent alanine aminotransferase elevation in healthy Swedish blood donors-mainly caused by obesity. R Wejstål G Hansson A Lindholm G Norkrans, Vox Sang 1988 55 152 156 10.1111/j.1423-0410.1988.tb05083.x 3238949
14. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A > T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. S Romeo F Sentinelli MG Cavallo F Leonetti M Fallarino S Mariotti MG Baroni, Int J Obes 2008 32 413 420 10.1038/sj.ijo. 0803743 (Pubitemid 351414813)
15. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
16. Insulin sensitivity indices obtained from oral glucose tolerance testing:comparison with the euglycemic insulin clamp. M Matsuda RA DeFronzo, Diabetes Care 1999 22 1462 1470 10.2337/diacare.22.9.1462 10480510 (Pubitemid 29418240)
17. Linkage disequilibrium of finite populations. WG Hill A Robertson, Theor Appl Genet 1968 38 226 231 10.1007/BF01245622
18. The interaction of selection and linkage 1. General considerations: heterotic models. RC Lewontin, Genetics 1984 49 49 67
19. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. WW Li MM Dammerman JD Smith S Metzger JL Breslow T Leff, J Clin Invest 1995 96 2601 2605 10.1172/JCI118324 8675624
20. The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. S Cauchi KT Nead H Choquet F Horber N Potoczna B Balkau M Marre G Charpentier P Froguel D Meyre, BMC Med Genet 2008 22 45 49
21. Heterogeneous effect of peroxisome proliferator-activated receptor gamma2 Ala12 variant on type 2 diabetes risk. O Ludovico F Pellegrini R Di Paola A Minenna S Mastroianno M Cardellini MA Marini F Andreozzi O Vaccaro G Sesti V Trischitta, Obesity 2007 15 1076 1081 10.1038/oby.2007.617 17495182 (Pubitemid 46932461)
22. Updated definitions of healthy ranges for serum alanine aminotransferase levels. D Prati E Taioli A Zanella E Della Torre S Butelli E Del Vecchio L Vianello F Zanuso F Mozzi S Milani D Conte M Colombo G Sirchia, Ann Intern Med 2002 137 1 10 12093239
23. Evaluation of abnormal liver-enzyme results in asymptomatic patients. DS Pratt MM Kaplan, N Engl J Med 2000 342 1266 1271 10.1056/NEJM200004273421707 10781624 (Pubitemid 30235957)
24. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. G Marchesini E Bugianesi G Forlani F Cerrelli M Lenzi R Manini S Natale E Vanni N Villanova N Melchionda M Rizzetto, Hepatology 2003 37 917 923 10.1053/jhep.2003.50161 12668987 (Pubitemid 36397405)
25. Liver fibrosis in overweight patients. V Ratziu P Giral F Charlotte E Bruckert V Thibault I Theodorou L Khalil G Turpin P Opolon T Poynard, Gastroenterology 2000 118 1117 1123 10.1016/S0016-5085(00)70364-7 10833486 (Pubitemid 30346988)
26. Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. C Richart T Auguet X Terra, N Engl J Med 2010 363 193 194 20647217
27. Transcriptional regulation of the apo C-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. M Chen JL Breslow W Li T Leff, J Lipid Res 1994 35 1918 1924 7868970 (Pubitemid 24353064)
28. Insulin resistance, the metabolic syndrome, and non-alcoholic fatty liver disease. F Angelico M Del Ben R Conti S Francioso K Feole S Fiorello MG Cavallo B Zalunardo F Lirussi C Alessandri F Violi, J Clin Endocrinol Metab 2005 90 1578 1582 15598693 (Pubitemid 40464021)
29. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. DN Amarapurka AD Amarapurkar ND Patel S Agal R Baigal P Gupte S Pramanik, Ann Hepatol 2006 5 30 33 16531962